According to CRISPR Therapeutics's latest financial reports the company's current revenue (TTM ) is โฌ30.06 Million. In 2024 the company made a revenue of โฌ33.63 Million a decrease over the revenue in the year 2023 that were of โฌ0.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.